Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Fabry Disease Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Fabry Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Fabry Disease Treatment Overall Market Size
2.1 Global Fabry Disease Treatment Market Size: 2022 VS 2029
2.2 Global Fabry Disease Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Fabry Disease Treatment Players in Global Market
3.2 Top Global Fabry Disease Treatment Companies Ranked by Revenue
3.3 Global Fabry Disease Treatment Revenue by Companies
3.4 Top 3 and Top 5 Fabry Disease Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Fabry Disease Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Fabry Disease Treatment Players in Global Market
3.6.1 List of Global Tier 1 Fabry Disease Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Fabry Disease Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Fabry Disease Treatment Market Size Markets, 2022 & 2029
4.1.2 Enzyme Replacement Therapy (ERT)
4.1.3 Chaperone Treatment
4.1.4 Substrate Reduction Therapy (SRT)
4.1.5 Others
4.2 By Type - Global Fabry Disease Treatment Revenue & Forecasts
4.2.1 By Type - Global Fabry Disease Treatment Revenue, 2018-2023
4.2.2 By Type - Global Fabry Disease Treatment Revenue, 2024-2029
4.2.3 By Type - Global Fabry Disease Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Fabry Disease Treatment Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Fabry Disease Treatment Revenue & Forecasts
5.2.1 By Application - Global Fabry Disease Treatment Revenue, 2018-2023
5.2.2 By Application - Global Fabry Disease Treatment Revenue, 2024-2029
5.2.3 By Application - Global Fabry Disease Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Fabry Disease Treatment Market Size, 2022 & 2029
6.2 By Region - Global Fabry Disease Treatment Revenue & Forecasts
6.2.1 By Region - Global Fabry Disease Treatment Revenue, 2018-2023
6.2.2 By Region - Global Fabry Disease Treatment Revenue, 2024-2029
6.2.3 By Region - Global Fabry Disease Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Fabry Disease Treatment Revenue, 2018-2029
6.3.2 US Fabry Disease Treatment Market Size, 2018-2029
6.3.3 Canada Fabry Disease Treatment Market Size, 2018-2029
6.3.4 Mexico Fabry Disease Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Fabry Disease Treatment Revenue, 2018-2029
6.4.2 Germany Fabry Disease Treatment Market Size, 2018-2029
6.4.3 France Fabry Disease Treatment Market Size, 2018-2029
6.4.4 U.K. Fabry Disease Treatment Market Size, 2018-2029
6.4.5 Italy Fabry Disease Treatment Market Size, 2018-2029
6.4.6 Russia Fabry Disease Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Fabry Disease Treatment Market Size, 2018-2029
6.4.8 Benelux Fabry Disease Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Fabry Disease Treatment Revenue, 2018-2029
6.5.2 China Fabry Disease Treatment Market Size, 2018-2029
6.5.3 Japan Fabry Disease Treatment Market Size, 2018-2029
6.5.4 South Korea Fabry Disease Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Fabry Disease Treatment Market Size, 2018-2029
6.5.6 India Fabry Disease Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Fabry Disease Treatment Revenue, 2018-2029
6.6.2 Brazil Fabry Disease Treatment Market Size, 2018-2029
6.6.3 Argentina Fabry Disease Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Fabry Disease Treatment Revenue, 2018-2029
6.7.2 Turkey Fabry Disease Treatment Market Size, 2018-2029
6.7.3 Israel Fabry Disease Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Fabry Disease Treatment Market Size, 2018-2029
6.7.5 UAE Fabry Disease Treatment Market Size, 2018-2029
7 Fabry Disease Treatment Companies Profiles
7.1 Sanofi S.A.
7.1.1 Sanofi S.A. Company Summary
7.1.2 Sanofi S.A. Business Overview
7.1.3 Sanofi S.A. Fabry Disease Treatment Major Product Offerings
7.1.4 Sanofi S.A. Fabry Disease Treatment Revenue in Global Market (2018-2023)
7.1.5 Sanofi S.A. Key News & Latest Developments
7.2 Takeda
7.2.1 Takeda Company Summary
7.2.2 Takeda Business Overview
7.2.3 Takeda Fabry Disease Treatment Major Product Offerings
7.2.4 Takeda Fabry Disease Treatment Revenue in Global Market (2018-2023)
7.2.5 Takeda Key News & Latest Developments
7.3 Amicus Therapeutics Inc.
7.3.1 Amicus Therapeutics Inc. Company Summary
7.3.2 Amicus Therapeutics Inc. Business Overview
7.3.3 Amicus Therapeutics Inc. Fabry Disease Treatment Major Product Offerings
7.3.4 Amicus Therapeutics Inc. Fabry Disease Treatment Revenue in Global Market (2018-2023)
7.3.5 Amicus Therapeutics Inc. Key News & Latest Developments
7.4 ISU Abxis Co Ltd.
7.4.1 ISU Abxis Co Ltd. Company Summary
7.4.2 ISU Abxis Co Ltd. Business Overview
7.4.3 ISU Abxis Co Ltd. Fabry Disease Treatment Major Product Offerings
7.4.4 ISU Abxis Co Ltd. Fabry Disease Treatment Revenue in Global Market (2018-2023)
7.4.5 ISU Abxis Co Ltd. Key News & Latest Developments
7.5 JCR Pharmaceuticals Co Ltd.
7.5.1 JCR Pharmaceuticals Co Ltd. Company Summary
7.5.2 JCR Pharmaceuticals Co Ltd. Business Overview
7.5.3 JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Major Product Offerings
7.5.4 JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Revenue in Global Market (2018-2023)
7.5.5 JCR Pharmaceuticals Co Ltd. Key News & Latest Developments
7.6 Protalix Biotherapeutics Inc.
7.6.1 Protalix Biotherapeutics Inc. Company Summary
7.6.2 Protalix Biotherapeutics Inc. Business Overview
7.6.3 Protalix Biotherapeutics Inc. Fabry Disease Treatment Major Product Offerings
7.6.4 Protalix Biotherapeutics Inc. Fabry Disease Treatment Revenue in Global Market (2018-2023)
7.6.5 Protalix Biotherapeutics Inc. Key News & Latest Developments
7.7 Idorsia Pharmaceuticals Ltd.
7.7.1 Idorsia Pharmaceuticals Ltd. Company Summary
7.7.2 Idorsia Pharmaceuticals Ltd. Business Overview
7.7.3 Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Major Product Offerings
7.7.4 Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Revenue in Global Market (2018-2023)
7.7.5 Idorsia Pharmaceuticals Ltd. Key News & Latest Developments
7.8 Avrobio Inc.
7.8.1 Avrobio Inc. Company Summary
7.8.2 Avrobio Inc. Business Overview
7.8.3 Avrobio Inc. Fabry Disease Treatment Major Product Offerings
7.8.4 Avrobio Inc. Fabry Disease Treatment Revenue in Global Market (2018-2023)
7.8.5 Avrobio Inc. Key News & Latest Developments
7.9 Greenovation Biotech GmbH
7.9.1 Greenovation Biotech GmbH Company Summary
7.9.2 Greenovation Biotech GmbH Business Overview
7.9.3 Greenovation Biotech GmbH Fabry Disease Treatment Major Product Offerings
7.9.4 Greenovation Biotech GmbH Fabry Disease Treatment Revenue in Global Market (2018-2023)
7.9.5 Greenovation Biotech GmbH Key News & Latest Developments
7.10 Moderna Therapeutics Inc.
7.10.1 Moderna Therapeutics Inc. Company Summary
7.10.2 Moderna Therapeutics Inc. Business Overview
7.10.3 Moderna Therapeutics Inc. Fabry Disease Treatment Major Product Offerings
7.10.4 Moderna Therapeutics Inc. Fabry Disease Treatment Revenue in Global Market (2018-2023)
7.10.5 Moderna Therapeutics Inc. Key News & Latest Developments
7.11 Green Cross Pharma Pte Ltd.
7.11.1 Green Cross Pharma Pte Ltd. Company Summary
7.11.2 Green Cross Pharma Pte Ltd. Business Overview
7.11.3 Green Cross Pharma Pte Ltd. Fabry Disease Treatment Major Product Offerings
7.11.4 Green Cross Pharma Pte Ltd. Fabry Disease Treatment Revenue in Global Market (2018-2023)
7.11.5 Green Cross Pharma Pte Ltd. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer